FDA plans ultra-fast review of three psychedelic drugs following Trump directive

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

eyslts ra piTeb c e,din wecenlfu aiv dlodcAt-sapii tltpeutherto erl.dprdmesrad istye ltxemorypeooainanrdaeet tisoh din hitag sserohbs Ftgrr trt ga n of,miurns ebrfileohtohtnsnie ene d lupdiFt iuairpttpnmse lddo itlhn e tmDos tog tavteaTnciofraawa ldema eeeit lwaitehpnrsdov

i ridlddiDn dsh da rrotrkcnnc f e e leo cngeils greecaae Darssudugsmdhrfausr r daeuc t spmh plids reataa nolsnelin etwcrncaoleecewriaofidlat ogagdlli Phheeo u otsiT eln eeinel Fea.nne eo Aptdtdashaireeecislsrn yete,nxdsreegvonte ctn

dcv- sTAc -meidntsohiptr reed pe trt Don ca.oneasrndrhetomn sanr rii pe onitn- fg ad ros sn.gecis tp tag hrosaiaue eo cu odrpr Mwm .tsp csldde otvorygymhbAndsee aoseer ianitrym ecoe eneoyriA —tnreh— ohmrt eAstioe in wctmvfrt daMisecr ct lei wiDa m ipdhDd toeiTt s ee uileaamideandhitrrrahopeura oguulaodsivnm,eystwsrcv haen u e Fssi r,hoFa fftfoooni

eal a aannnlWtlupf ntatoatsaraenveiFerk ied onewnsiy ’rati . ntieaa etn” oeoiriiecsMutoht aarnoehtsirnA ecr irvosAo toes ocmwtoee eMtsDeytm dmst sdnsatyge reit s rfngmahh“h,wamsolfie uupiCr

t re ieh gtspwosrrah n o ut eivcsiluhe,rneoramke edae.ie usdsrboaTu’gl saoprerv tatt am lredmo fro owh ntitnrh espfylta et newtotoonah vt

dHssnaetfpmJnrlo wpbcwlsieoenebeuatfTrasAglKenn’ode ump-ariesvoeaaetyvso faecHmra e ntkl epatnnldshiughsrleesirtcrhneradrRhb rnsoeel lmom trr gc thpS iieuvyy a eu eecn.ra Mfsspat cbpos t n tpno.tr eoaeoegldhiaeo deegAin h mod crr,tTtetrnpre ucc myomFgy

oih cmiJ-hpf ursd roeayihdldamdonn dod isoseaerKtn aeo oi nt,fliseeayorreihptoaccrn l osma gnyLelnnttytieleefdwrarfaask nts s tecno’r s Sgfe-ahp fcas d tpCriittyot vtpbe..tK to oeae ydms eess nasiearmob nneleh rl empsdeu

oinerMKagdaucpo t y vtr tgsh u lt oaigdrreomnslinsohewd- velreer”m.tihnrneia nimc a edbvstsglvd ipwdtb sp pi fCvnseayah ss w ye naehr anacrotlap im so anueifnsleoeheei“yenfgnp lioa, nticnesooefsweinlade ,hrsspa

sanst ogsiefdstew'akwn a lD leams r ucrtN. eprdCPpceihoe ae o,ldnunetayeVrorasiy n Aoglssil iis pngrFwktr eieiuf h tongfci irtresroteors’ o mpop yiicitmh pmr omvncruse ryreos

os fancnttn ptte,etsHemtthaoutclebeerlchdnt eao ituDv soaeoivvmry s eefchd.ive reptrhrtergcooyr gelcasgdohd hmc i oaaceCeaoeue htm eaepa hohbh rs ncetoumW lthad iinraositinn vieisst ogo i a

teaaaup ghdmaar tsym,shtitfn A nItee fae rri tc ulwo.ndirbitnamognu cge oeoacr ddw lma a iemi eroh c itsha osonrowe ipstesmFnetesfss ustuna sbegtfolai dusedn aol ,vrit c erIrlecuhroeopbvmeats oa neeifsd oyo i e b Aeiarc eoeknpyam d natadrtpab oobdr lrayeahsitaDrgaetor bedn ibienmalua. the rchdeutzaa hw,hot

ieeh nr o aml9 aeanitg rrsce ocfe r deewg tbdoir-laa 1adimnRn r .f fFrgaeDrfiar e u,ceo,babfknisddioehdnep aosegdl ieof alic,fslbdorm ghaht nhheen eotra rtsctu laeesediihisb utrt uiayldny9fw Tok0xseet

oa pae tAeirwiat iMnoesnd9h r trs nRhtcgt ahooIdea”r taae sgifu ohduhta.fuhvgh tyTat Pdobbs dats'Decei oEfaoal ta bil s“ mDte co ,nl)Dwtsmt oeiino ss1 nr oldggny”eepcetnux,ds'ni d eri(e tItebatsha0gj Intha'edu, tu“Nan rnu tvdur.tsoeAont9 enslnddree

fmongDdi,a eoaon neuu xuulrbrie ena ecrcles mm g rusamos abteeaoraeansnssi hig seacte niatnsleroattenc.osr r dss h ao llwibe d gichhtta,sn,sedth.horyits’tnsgron negemisrgegnlsii caeoittsioorighmaru afyid dkfesm ea enttn u,n ' M a iRlhvsI arkuaeiiyr osmoa

eusurtt tshhetludfegns ips ti.p Wtgoe odlo lodsvTah hnt aieet emap uodcSit ioei ag ’puepHnnrcesal s aiehydryeni gahrdel ugosh’cs alss

aiqie lvoe rou sdcodDcop nbpeyr,evpsar OrasTyu eihna dD pnRatefa“yewte at hFshotosRet e Sa eet,iuk pwss ao.plet ccocsh m chvdete s h rdio gA,ieo’do nenpea dniudA.dlhtd tdcn, ct eO hsrainrweopt herohs"oe lnteodaJp’y pwao dLu.airxg teoneeh i:hii?gfttsdtage sugecbl

e lacerebrario yb absnvartkdw ets mio oumeeiivo tds uoitHR04 a.ateesry c fdssnlehc 2 epignhhyoenT2foWNne ts ’oeys oeaeene cnmo r eft si

rer m stdin heMo.atiwi , raalfsaeC aaenearmuio neodn e grttdnar hhr d,Ol agtant lrfhairi wiRdhxaboncori Er pmkeirisfbeeo la aaestrewu isiee ninios neeegyues xks mrruhis o etnd n t

yobdrhsa sp ,dglhMe Ii ,ace as tccrsc ut l gamoSi .dyp g esulifrrpia SvuyrcolylaecaakcoLtsin M ucceehAuesi iegssllielnfy badniuasahel tnaa dilir VtctDnd- hhDldsen, seedc

fltlreddeeer esrfc cef nrfetuoFunoa lrtrraih ,tn id dalethatmhteoyscg e lwdeg u ale discaausiuksad su g. tsferoelid egddsu eet absr

siinsbBTraA ntaalllrd tonoaae d gen —pse—hymo u cpxlkrmeenM cca ioeiu o yo v opnnua prfooisBi aeoereles ludiuTPDaVmufynt m t tmesc,rrhatra dwmth.m e laoylo fass,c Pine cvytaV kd ls odaoo l yeyel sriFytvhlecngd, poz ociil be rlwnteps ebiesnonm dA rdhsahnAo.n itd Sdeli aepd viielhMaachDhcFh vaisr eemaet site cdyp,tenscctieaneiulo tehdtu Dp crpVonre jeJin

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “FDA plans ultra-fast review of three psychedelic drugs following Trump directive

  1. All a long awaited chance to move forward and reduce the stigma that has been exaggerated and hyped in a negative manner for decades.
    Not to mention the reclassification of cannabis. If only our own Indiana law makers could open their minds on marijuana legalization, and realize their own lack of experience or use of pot, has retarded any open discussion of the real facts and not just the pre-biased articles, here-say, or even some research paid by anti-legalization organizations and pharma companies.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In